CHU Bicêtre

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Myasthenia gravis1 trial
• Stroke1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Assistance Publique - Hôpitaux de Paris2 trials
• Regeneron Pharmaceuticals1 trial

Running trials

• Not yet recruiting

  Influence of Individual Traits on Adaptation Processes in Individuals With Alcohol Use Disorder

  NCT07468825· Assistance Publique - Hôpitaux de Paris· Source

  Contact: Catherine MARTELLI, PhD

• Recruiting

  PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

  NCT05387954· Phase 3· Assistance Publique - Hôpitaux de Paris· Source

  Contact: Christian Denier, MD

• Active, not recruiting

  A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

  NCT05070858· Phase 3· Regeneron Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke1 recruiting